Status:
COMPLETED
The Significance of Postoperative Muscle Wasting in Pancreatic Cancer
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
20-120 years
Brief Summary
To assess the impact of preoperative sarcopenia and postoperative skeletal muscle wasting on the outcomes of patients with resectable pancreatic cancer who underwent pancreatectomy.
Detailed Description
Previous studies have revealed that sarcopenia, defined as generalized loss of skeletal muscle mass, is a poor prognostic factor following surgery. However, research focusing on postoperative muscle w...
Eligibility Criteria
Inclusion
- Clinical diagnosis of pancreatic cancer
- Must be able to undergo pancreatectomy
- Must be able to undergo pre- and post-operative abdominal computed tomography scan
Exclusion
- Unresectable pancreatic cancer
Key Trial Info
Start Date :
June 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2023
Estimated Enrollment :
208 Patients enrolled
Trial Details
Trial ID
NCT06093009
Start Date
June 1 2002
End Date
June 1 2023
Last Update
October 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University Hospital
Tainan, Taiwan